Therapy
Areas
Together with our partners at Roche, Chugai are consistently striving to be a trusted member of the haemophilia community, changing the treatment
landscape to help people with haemophilia A.
Our experience in oncology and supportive care began in 1994 with a commitment that’s clearly focused on
the future.
From research through to supporting patient care, Chugai and our partners
at Roche are committed to supporting the rheumatology community and their patients in working towards optimal outcomes.
Keep up to date with our innovative medicines and to make sure you are the first to hear more about future resources.
You can also follow Chugai Pharma on LinkedIn
C-GB-00000310 | December 2022